Medical Dosimetry
Volume 35, Issue 1 , Pages 38-42 , Spring 2010

Factors Influencing Conformity Index in Radiotherapy for Non–Small Cell Lung Cancer

  • Sinead M. Brennan, M.D.

      Affiliations

    • Department of Radiation Oncology, St. Lukes Hospital, Dublin, Ireland
    • Corresponding Author InformationReprint requests to: Sinead M. Brennan, M.D., Department of Radiation Oncology, St. Luke's Hospital, Highfield Road, Rathgar, Dublin 6, Ireland
    • ,
  • Pierre Thirion, M.D.

      Affiliations

    • Clinical Trials Unit, St. Lukes Hospital, Dublin, Ireland
    • ,
  • Steve Buckney

      Affiliations

    • Department of Physics, St. Lukes Hospital, Dublin, Ireland
    • ,
  • Carmel O. Shea

      Affiliations

    • Clinical Trials Unit, St. Lukes Hospital, Dublin, Ireland
    • ,
  • John Armstrong, M.D.

      Affiliations

    • Department of Radiation Oncology, St. Lukes Hospital, Dublin, Ireland

References 

  1. International Commission on Radiation Units and Measurements. ICRU Report 50 (Prescribing, Recording and Reporting Photon Beam Therapy). Bethesda, MD: ICRU; 1993;
  2. Shaw E, Kline R, Gillin M, et al. Radiation Therapy Oncology Group: Radiosurgery quality assurance guidelines. Int. J. Radiat. Oncol. Biol. Phys. 1993;27:1231–1239
  3. Knöös TK, Kristensen I, Nilsson P. Volumetric and dosimetric evaluation of radiation treatment plans: Radiation conformity index. Int. J. Radiat. Oncol. Biol. Phys. 1998;42:1169–1176
  4. Murshed H, Helen Liu H, Liao Z, et al. Dose and volume reduction for normal lung using intensity modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2004;58:1258–1267
  5. Feuvret L, Noel G, Mazeron JJ, et al. Conformity index: A review. Int. J. Radiat. Oncol. Biol. Phys. 2006;64:333–342
  6. Brennan S, Fitzpatrick D, Armstrong J, et al. Hypofractionated accelerated high dose radiotherapy (RT) in non-small cell lung cancer. (Abstr. 7527) J. Clin. Oncol. 2008;26:
  7. Thirion P, Holmberg O, Collins CD, et al. Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy. Radiother. Oncol. 2004;71:163–166
  8. International Commission on Radiation Units and Measurements. ICRU Report 62 (Prescribing, Recording and Reporting Photon Beam Therapy. Supplement to ICRU Report 50). Bethesda, MD: ICRU; 1999;
  9. Rozenzweig KE, Sim SE, Mychalczaczak B, et al. Elective nodal irradiation in the treatment of non-small cell lung caner with three-dimensional conformal radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 2001;50:681–685
  10. Timmerman R, Glavin J, Michalski J, et al. Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicentre clinical trials using Stereotactic Body Radiation Therapy in Lung Cancer RTOG 0236. Acta Oncol. 2006;45:779–786
  11. McGibney C, Holmberg O, McClean B, et al. Analysis of dose distribution in the “Rind”—a volume outside the PTV—in 3-dimensional conformal radiation therapy of non small cell lung cancer. Radiother. Oncol. 2003;66:87–93
  12. Hamilton RJ, Kuchnir FT, Sweeney P, et al. Comparison of static conformal field with multiple noncoplanar arc techniques for stereotactic radiosurgery or stereotactic radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1995;33:1221–1228
  13. Higgins PD, Sohn JW, Fine RM, et al. Three dimensional conformal pancreas treatment: Comparison of four to six field techniques. Int. J. Radiat. Oncol. Biol. Phys. 1995;31:605–609

PII: S0958-3947(09)00005-3

doi: 10.1016/j.meddos.2009.01.003

Medical Dosimetry
Volume 35, Issue 1 , Pages 38-42 , Spring 2010

Article Tools